0

Close
 
Upcoming Allied Market Research
2023
Vascular Dressings Market

Vascular Dressings Market

by Product Type (Antimicrobial Vascular Dressings, Non-Antimicrobial Vascular Dressings) and by End User (Hospitals, Clinics, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals
Report Code: A12685
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Vascular Dressings Market

Request Now !

Vascular dressings are also known as intravenous site dressings are used for protection of the vascular site having an injury. These are used to prevent infections that can occur at the insertion site. Since the IV sites are prone to viral and bacterial infections, these dressings are significant. Vascular dressings are not only used to prevent infection at the site but also to ensure the line in place for better management. Another common application of vascular dressings is securing surgical incisions, superficial wounds like abrasions, minor burns, and securing catheter sites. Vascular dressings aid the excess moisture to free while maintaining a moist wound healing environment which is required for healing of the wound.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the vascular dressings market.

Top Impacting Factors

  • Rise in cases of hospital-acquired infections at the intravenous site, increase in birth-related hospitalizations and road accidents, and surge in the geriatric population who is more prone to surgeries & hospitalization, are factors that drive the growth of the vascular dressings market.
  • In addition, increase in healthcare expenditure; availability of skilled professionals; rise in R&D activities to launch novel developed products in the market are some factors, which boost the market growth for vascular dressings.
  • However, affordability and accessibility in remote parts of the world may hinder the vascular dressings market growth.

Vascular Dressings Market Trends

New product launches to flourish the market

In 2016, Beckton Dickinson and Company and Vancive Medical Technologies launched a line of transparent vascular dressings with chlorhexidine gluconate (CHG) antimicrobial preservatives. It was intended to improve patient care and be comfortable for clinicians to apply and remove.

Key Benefits of the Report

  • This study presents the analytical depiction of the vascular dressings industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the vascular dressing’s market share.
  • The current market is quantitatively analyzed to highlight the vascular dressing’s market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the vascular dressings market.
  • The report provides a detailed vascular dressings market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the vascular dressings Report

  • Which are the leading players active in the vascular dressings market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the vascular dressings market?
  • What future projections would help in taking further strategic steps?
  • What is "Vascular dressings"?
  • What is "Vascular dressings" Market prediction in the future?
  • Who are the leading global players in the "Vascular dressings" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Vascular dressings" Market report?

 Vascular Dressings Market Report Highlights

Aspects Details
By Product Type
  • Antimicrobial Vascular Dressings
  • Non-Antimicrobial Vascular Dressings
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Reliamed, B Braun, Derma Sciences, BSN Medical (Essity), Vancive Medical Technologies (Avery Dennison), Smith and Nephew, BD, 3M, Mölnlycke Health Care, Medline, Systagenix, Richardson Healthcare
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: VASCULAR DRESSINGS MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Antimicrobial Vascular Dressings

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Non-Antimicrobial Vascular Dressings

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: VASCULAR DRESSINGS MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Ambulatory Surgical Centers

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: VASCULAR DRESSINGS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Vascular Dressings Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Vascular Dressings Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Vascular Dressings Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Vascular Dressings Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Vascular Dressings Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Vascular Dressings Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Vascular Dressings Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Vascular Dressings Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Vascular Dressings Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Vascular Dressings Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Vascular Dressings Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Vascular Dressings Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Vascular Dressings Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Vascular Dressings Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Vascular Dressings Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Vascular Dressings Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Vascular Dressings Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Vascular Dressings Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Vascular Dressings Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Vascular Dressings Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Vascular Dressings Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Vascular Dressings Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Vascular Dressings Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Vascular Dressings Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Vascular Dressings Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. BD

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Vancive Medical Technologies (Avery Dennison)

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. BSN Medical (Essity)

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Richardson Healthcare

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Derma Sciences

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Mölnlycke Health Care

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Smith And Nephew

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. 3M

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. B Braun

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Systagenix

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

    • 8.11. Reliamed

      • 8.11.1. Company Overview

      • 8.11.2. Key Executives

      • 8.11.3. Company Snapshot

      • 8.11.4. Operating Business Segments

      • 8.11.5. Product Portfolio

      • 8.11.6. Business Performance

      • 8.11.7. Key Strategic Moves and Developments

    • 8.12. Medline

      • 8.12.1. Company Overview

      • 8.12.2. Key Executives

      • 8.12.3. Company Snapshot

      • 8.12.4. Operating Business Segments

      • 8.12.5. Product Portfolio

      • 8.12.6. Business Performance

      • 8.12.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL VASCULAR DRESSINGS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL VASCULAR DRESSINGS MARKET FOR ANTIMICROBIAL VASCULAR DRESSINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL VASCULAR DRESSINGS MARKET FOR NON-ANTIMICROBIAL VASCULAR DRESSINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL VASCULAR DRESSINGS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL VASCULAR DRESSINGS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL VASCULAR DRESSINGS MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL VASCULAR DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL VASCULAR DRESSINGS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. NORTH AMERICA VASCULAR DRESSINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. U.S. VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 13. U.S. VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. CANADA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. CANADA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE VASCULAR DRESSINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. FRANCE VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. FRANCE VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. GERMANY VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 24. GERMANY VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. ITALY VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. ITALY VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. SPAIN VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. SPAIN VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. UK VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. UK VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. RUSSIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. RUSSIA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. REST OF EUROPE VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. REST OF EUROPE VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC VASCULAR DRESSINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. CHINA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. CHINA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. JAPAN VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. JAPAN VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. INDIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. INDIA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. SOUTH KOREA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. AUSTRALIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. AUSTRALIA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. THAILAND VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 49. THAILAND VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. MALAYSIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. MALAYSIA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. INDONESIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. INDONESIA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. LAMEA VASCULAR DRESSINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 57. LAMEA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. BRAZIL VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. BRAZIL VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. SOUTH AFRICA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH AFRICA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. SAUDI ARABIA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SAUDI ARABIA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. UAE VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. UAE VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. ARGENTINA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 68. ARGENTINA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. REST OF LAMEA VASCULAR DRESSINGS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF LAMEA VASCULAR DRESSINGS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. BD: KEY EXECUTIVES
  • TABLE 72. BD: COMPANY SNAPSHOT
  • TABLE 73. BD: OPERATING SEGMENTS
  • TABLE 74. BD: PRODUCT PORTFOLIO
  • TABLE 75. BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): KEY EXECUTIVES
  • TABLE 77. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): COMPANY SNAPSHOT
  • TABLE 78. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): OPERATING SEGMENTS
  • TABLE 79. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): PRODUCT PORTFOLIO
  • TABLE 80. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. BSN MEDICAL (ESSITY): KEY EXECUTIVES
  • TABLE 82. BSN MEDICAL (ESSITY): COMPANY SNAPSHOT
  • TABLE 83. BSN MEDICAL (ESSITY): OPERATING SEGMENTS
  • TABLE 84. BSN MEDICAL (ESSITY): PRODUCT PORTFOLIO
  • TABLE 85. BSN MEDICAL (ESSITY): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. RICHARDSON HEALTHCARE: KEY EXECUTIVES
  • TABLE 87. RICHARDSON HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 88. RICHARDSON HEALTHCARE: OPERATING SEGMENTS
  • TABLE 89. RICHARDSON HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 90. RICHARDSON HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. DERMA SCIENCES: KEY EXECUTIVES
  • TABLE 92. DERMA SCIENCES: COMPANY SNAPSHOT
  • TABLE 93. DERMA SCIENCES: OPERATING SEGMENTS
  • TABLE 94. DERMA SCIENCES: PRODUCT PORTFOLIO
  • TABLE 95. DERMA SCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. MöLNLYCKE HEALTH CARE: KEY EXECUTIVES
  • TABLE 97. MöLNLYCKE HEALTH CARE: COMPANY SNAPSHOT
  • TABLE 98. MöLNLYCKE HEALTH CARE: OPERATING SEGMENTS
  • TABLE 99. MöLNLYCKE HEALTH CARE: PRODUCT PORTFOLIO
  • TABLE 100. MöLNLYCKE HEALTH CARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 102. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 103. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 104. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 105. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. 3M: KEY EXECUTIVES
  • TABLE 107. 3M: COMPANY SNAPSHOT
  • TABLE 108. 3M: OPERATING SEGMENTS
  • TABLE 109. 3M: PRODUCT PORTFOLIO
  • TABLE 110. 3M: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. B BRAUN: KEY EXECUTIVES
  • TABLE 112. B BRAUN: COMPANY SNAPSHOT
  • TABLE 113. B BRAUN: OPERATING SEGMENTS
  • TABLE 114. B BRAUN: PRODUCT PORTFOLIO
  • TABLE 115. B BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. SYSTAGENIX: KEY EXECUTIVES
  • TABLE 117. SYSTAGENIX: COMPANY SNAPSHOT
  • TABLE 118. SYSTAGENIX: OPERATING SEGMENTS
  • TABLE 119. SYSTAGENIX: PRODUCT PORTFOLIO
  • TABLE 120. SYSTAGENIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. RELIAMED: KEY EXECUTIVES
  • TABLE 122. RELIAMED: COMPANY SNAPSHOT
  • TABLE 123. RELIAMED: OPERATING SEGMENTS
  • TABLE 124. RELIAMED: PRODUCT PORTFOLIO
  • TABLE 125. RELIAMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126. MEDLINE: KEY EXECUTIVES
  • TABLE 127. MEDLINE: COMPANY SNAPSHOT
  • TABLE 128. MEDLINE: OPERATING SEGMENTS
  • TABLE 129. MEDLINE: PRODUCT PORTFOLIO
  • TABLE 130. MEDLINE: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR DRESSINGS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL VASCULAR DRESSINGS MARKET
  • FIGURE 3. SEGMENTATION VASCULAR DRESSINGS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN VASCULAR DRESSINGS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALVASCULAR DRESSINGS MARKET
  • FIGURE 11. VASCULAR DRESSINGS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. VASCULAR DRESSINGS MARKET FOR ANTIMICROBIAL VASCULAR DRESSINGS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. VASCULAR DRESSINGS MARKET FOR NON-ANTIMICROBIAL VASCULAR DRESSINGS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. VASCULAR DRESSINGS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 15. VASCULAR DRESSINGS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. VASCULAR DRESSINGS MARKET FOR CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. VASCULAR DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: VASCULAR DRESSINGS MARKET
  • FIGURE 24. Top player positioning, 2022
  • FIGURE 25. BD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 26. BD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 27. BD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 28. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. VANCIVE MEDICAL TECHNOLOGIES (AVERY DENNISON): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. BSN MEDICAL (ESSITY): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. BSN MEDICAL (ESSITY): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. BSN MEDICAL (ESSITY): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. RICHARDSON HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. RICHARDSON HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. RICHARDSON HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. DERMA SCIENCES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. DERMA SCIENCES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. DERMA SCIENCES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. MöLNLYCKE HEALTH CARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. MöLNLYCKE HEALTH CARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. MöLNLYCKE HEALTH CARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. SMITH AND NEPHEW: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. 3M: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. 3M: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. 3M: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. B BRAUN: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. B BRAUN: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. B BRAUN: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. SYSTAGENIX: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. SYSTAGENIX: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. SYSTAGENIX: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. RELIAMED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. RELIAMED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. RELIAMED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. MEDLINE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. MEDLINE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. MEDLINE: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Vascular Dressings Market

Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers